Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. Their research, published in Nature ...

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

Newsweek has created a map showing states where respiratory syncytial virus (RSV) cases are surging.

for increased sickness. The winter and holiday season is typically when more people get sick, particularly with respiratory viruses such as the flu, RSV and COVID-19. While most of us have heard ...

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged ...

As colder weather sets in, common illnesses such as the cold, flu, RSV and COVID-19 viruses are making their way around Oregon. Here's what to know.

Respiratory syncytial virus, or RSV, is a common cvirus that infects the nose, throat and lungs, according to the U.S Centers for Disease Control and Prevention. Is it RSV, COVID or the flu?

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Though there are now respiratory syncytial virus (RSV) vaccines approved by the FDA and recommended by the CDC for ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the ...